Switzerland Faces Pressure From US Drug Pricing Policy
6 Articles
6 Articles
The US administration's new policy to reduce drug prices is causing concern in Switzerland, as pharmaceutical companies may seek price increases in other markets to compensate for potential losses in the US. According to a study by researchers from the Swiss Federal Institute of Technology in Zurich (ETH) and the University of Zurich, if Switzerland and other countries give in to this pressure, Swiss citizens could face hundreds of millions of f…
Experts at the University of Zurich consider it unlikely that the US would demand higher drug prices from Switzerland. Little was left of the idea of most-favoured-nation.
New study shows that US pressure on drug prices could cost Switzerland hundreds of millions of Swiss francs a year.
A new study shows that US pressure on drug prices could cost Switzerland hundreds of millions of francs a year.
The US president wants to reduce drug prices in the US, but the plan could be really expensive for Swiss insured people. A new study shows why pharmaceutical companies have the incentive to increase prices because of Trump – also in Switzerland.
Coverage Details
Bias Distribution
- 75% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
